It was discovered more than 30 years ago, and in all that time, not one controlled human trial of it has been published
Why receptor subtype work matters for interpretation A common question is which receptor subtype is doing the work. A 2025 mechanistic study investigated AMY receptor subtype dependence and reported that cagrilintides body weight lowering effects depended on AMY1R and AMY3R in their models, which provides a more concrete receptor anchored explanation than general appetite language
Large Organization, Agility
In some cases, the answer may actually be yes
Strict Research Use Only (RUO) Notice All tesamorelin and other peptides offered by HealthLab Peptides including but not limited to CJC-1295, Hexarelin, IGF-1 LR3, Semaglutide, Tirzepatide, Retatrutide, MOTS-c, BPC-157, and GHK-Cu are Research Use Only (RUO) materials